Acquisitions - Narrative (Details) - BioDiscovery - USD ($) $ in Thousands, shares in Millions |
1 Months Ended | 3 Months Ended | 6 Months Ended |
|---|---|---|---|
Oct. 31, 2021 |
Mar. 31, 2022 |
Jun. 30, 2022 |
|
| Business Acquisition [Line Items] | |||
| Cash consideration transferred in acquisition | $ 52,291 | ||
| Consideration transferred, common stock (in shares) | 40.0 | ||
| Milestone payment payable | $ 10,000 | ||
| Value of shares subject to vesting | $ 26,000 | ||
| Increase in acquired contract liabilities | $ 94 | ||
| Intangible assets useful life | 5 years |
| X | ||||||||||
- Definition Business Acquisition, Consideration Transferred, Value Of Shares, Subject To Vesting No definition available.
|
| X | ||||||||||
- Definition Business Acquisition, Milestone Payment Payable No definition available.
|
| X | ||||||||||
- Definition Business Combination, Consideration Transferred, Shares No definition available.
|
| X | ||||||||||
- Definition Business Combination, Recognized Identifiable Asset Acquired and Liability Assumed, Contract Liability, Increase (Decrease) in Fair Value No definition available.
|
| X | ||||||||||
- Definition Weighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|